Zyversa Therapeutics Stock Analysis

ZyVersa Stock Analysis Notes

The company has Price to Book (P/B) ratio of 0.49. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. ZyVersa Therapeutics recorded a loss per share of 958.35. The entity had not issued any dividends in recent years. The firm had 1:10 split on the 26th of April 2024. For more information please call the company at 754 231 1688 or visit https://www.zyversa.com.

ZyVersa Therapeutics Investment Alerts

ZyVersa Therapeutics Upcoming and Recent Events

ZyVersa Largest EPS Surprises

View All Earnings Estimates

ZyVersa Therapeutics Environmental, Social, and Governance (ESG) Scores

ZyVersa Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 4.06 M.

ZyVersa Profitablity

Management Efficiency

ZyVersa Therapeutics has return on total asset (ROA) of (0.1158) % which means that it has lost $0.1158 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.8017) %, meaning that it created substantial loss on money invested by shareholders. ZyVersa Therapeutics' management efficiency ratios could be used to measure how well ZyVersa Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. As of June 5, 2024, Return On Tangible Assets is expected to decline to -29.78. The current year's Return On Capital Employed is expected to grow to -1.15. At present, ZyVersa Therapeutics' Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Current Assets Total is expected to grow to about 36.2 M, whereas Net Tangible Assets are forecasted to decline to (11.6 M).

Technical Drivers

As of the 5th of June, ZyVersa Therapeutics maintains the Standard Deviation of 7.36, mean deviation of 4.98, and Market Risk Adjusted Performance of (0.33). Relative to fundamental indicators, the technical analysis model lets you check existing technical drivers of ZyVersa Therapeutics, as well as the relationship between them.

ZyVersa Therapeutics Price Movement Analysis

ZyVersa Therapeutics Insider Trading Activities

ZyVersa Therapeutics Predictive Daily Indicators

ZyVersa Therapeutics Corporate Filings

ZyVersa Therapeutics Forecast Models

ZyVersa Therapeutics' time-series forecasting models are one of many ZyVersa Therapeutics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary ZyVersa Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how ZyVersa Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling ZyVersa shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as ZyVersa Therapeutics. By using and applying ZyVersa Stock analysis, traders can create a robust methodology for identifying ZyVersa entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. ZyVersa analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. ZyVersa analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

ZyVersa Therapeutics stock analysis indicators help investors evaluate how ZyVersa Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading ZyVersa Therapeutics shares will generate the highest return on investment. By understating and applying ZyVersa Therapeutics stock analysis, traders can identify ZyVersa Therapeutics position entry and exit signals to maximize returns.

When running ZyVersa Therapeutics' price analysis, check to measure ZyVersa Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ZyVersa Therapeutics is operating at the current time. Most of ZyVersa Therapeutics' value examination focuses on studying past and present price action to predict the probability of ZyVersa Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ZyVersa Therapeutics' price. Additionally, you may evaluate how the addition of ZyVersa Therapeutics to your portfolios can decrease your overall portfolio volatility.